October 5, 2023 – On October 2, 2023, the Heart Rhythm Society and the U.S. Food and Drug Administration (FDA) hosted a webinar on the agency’s role in regulating medical devices.
During the webinar panelists discussed regulatory pathways used to determine safety and effectiveness of medical devices, and strategic initiatives underway to quickly introduce new technology into the marketplace. The panelists also provided information on collaborative opportunities for investigators, how recalls are determined, and more.
In case you missed it, the webinar is available on the online learning resource center, Heart Rhythm 365.
HRS Endorsed
- No
Topic
- Advocacy
- Regulatory Updates
Post Type
- Advocacy in Action
Related Posts

Advocacy in Action
HRA Continues to Advocate to Stop Medicare Physician Payment Cuts
Congress successfully passed a continuing resolution (CR) ahead of the March 14th deadline for avoiding a federal government shutdown.
April 1, 2025

Advocacy in Action
HRA Monitoring MedPAC Recommendations on Physician Payment Reform
Heart Rhythm Advocates (HRA) continues to closely monitor Medicare Payment Advisory Commission’s (MedPAC) recommendations on potential reforms to Medicare physician payments.
April 1, 2025

Advocacy in Action
HRA Continues to Push for Medicare Physician Payment Fix as Senate Democrats Release Standalone Health Bill
Senate Democratic leaders have introduced standalone legislation containing the bipartisan health care policies that were originally slated for inclusion in the 2024 year-end package.
April 1, 2025